Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Spero Therapeutics Has Appointed Esther Rajavelu As CFO And Chief Business Officer, Succeeding Stephen Dipalma, Who Has Served As The Company's Interim CFO Since August 1, 2023

Author: Benzinga Newsdesk | November 01, 2023 08:13am

Posted In: SPRO